the true incidence of the condition. Finally, there is much that we do not know about this disease and its prognosis.
Bernstein et alt first described sarcoid lesions of the heart in 1929 and 10 years later Gentzen2 reported the first death from myocardial sarcoid. In subsequent years many reports of small numbers of cases and reviews of published series appeared, such as that of Porter.3 Many of the patients were negroes in the southern United States and this fact still tends to be overemphasised. 4 However, most of the cases in the United Kingdom are white.
In the United Kingdom the sole report of a fatal case was the classic one of Forbes This, of course, adds up to more than 163 because some cases present with more than one feature. Any possible bearing of the sarcoid on the three cases of road traffic accident is uncertain. Sarcoid heart disease should be suspected in any case of unusual cardiac disease for which there is no other explanation. The ultimate proof of the diagnosis is by necropsy and it is, therefore, with particular regret that we record a disappointing number and quality of necropsies in this series."
In the living the diagnosis is made on the following grounds: (1) cardiac condition consistent with sarcoid heart disease; (2) clinical diagnosis of sarcoidosis; (3) histological confirmation of sarcoidosis-this should be sought wherever possible either on suspicion of the diagnosis or to confirm the clinical diagnosis. In the absence of any other biopsy material the Kveim test or a transbronchial biopsy can be of diagnostic value.
Subclinical cardiac involvement is probably very common in classical sarcoidosis. Silverman et at12
report cardiac granulomata in 27% of patients 641 dying of sarcoid. However, the heart may be massively involved while there is minimal involvement in other organs. 7 Endomyocardial biopsy has occasionally been positive and, of course, this is diagnostic, but a negative result is of no importance" because of the patchy distribution of the disease in the myocardium.
Geographical distribution
Although it is generally agreed that there are wide differences in the incidence of sarcoidosis in different areas and ethnic groups, accurate information about incidence (as opposed to prevalence) is available for only a few areas and groups. '3 In Britain the British Thoracic and Tuberculosis Association14 compared the incidence in four areas. This varied from 0-21 per 10 000 among men in the most northerly area to 0 45 per 10 000 among women in the most southerly, with a generally lower incidence in the north.
The distribution of the centres through which cases of sarcoid heart disease have been reported to me is as follows: East Anglia 62, London 28, Oxford area 22, elsewhere 51, giving the total of 163.
No cases have been reported from the West country, even from the Devon Heart Block and Bradycardia Survey'5 and yet in the UK study of sarcoid14 this area had the highest incidence. St George's Hospital, London with their long experience of heart block report no cases. Only 17 of the 163 cases reported came from north of Leicester, in spite of good communication with consultants in the north.
The 62 cases from East Anglia with a population of only two million is, therefore, remarkable. Three necropsy cases ranging in age from 25 to 41 years came from the City of Ely with a population of only 10 000.
If this discrepancy of distribution is real it could be of importance. In the meantime I assume that proximity to my known interest in Cambridge largely accounts for this distribution. I hope our efforts will enable us to compile a complete East Anglian register.
Prognosis and treatment
The prognosis in the individual case is extremely variable and it is difficult to know how actively to pursue treatment in the symptom-free case. Heart block, arrhythmia, and heart failure should obviously be treated in their own right, but when should steroids be given? The incidence of sudden death is very disturbing and clinicians having made the diagnosis of myocardial sarcoid cannot have any sense of security. There is recent evidence that sarcoid heart disease could have been involved in more than one fatal air crash. The matter is, therefore, of considerable importance.
Suspected cases should at least be investigated by 24-hour ECG tape monitoring, echocardiography, exercise testing, and probably by radionucleide myocardial imaging and estimations of angiotensin converting enzyme (ACE),'6 in an attempt to assess cardiac involvement and the activity of the sarcoidosis.
The collection of data about all cases of sarcoid heart disease appears to be the best way of assessing the importance of this condition and its natural history. It is to be hoped that other countries will follow the lead of Japan in establishing national registers for the collation of information.
In the United Kingdom there is no such national study but the present collection of cases continues, and it already provides a useful reservoir of clinical experience. Thus, if you have a proven or even a suspected case, please let me have details. 
